MRKR

Marker Therapeutics, Inc.

Company with tickers: MRKR

CIK

1094038

CUSIP

57055L206

Shares Outstanding

16,673,127

Website

https://www.markertherapeutics.com

13F Activity (30d)

3 filings 2 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2018-12-31	$71,710	—	—	10-K, filed 2020-03-12
2017-12-31	$310,493	—	—	10-K, filed 2019-03-15
2016-12-31	$0	—	—	10-K, filed 2018-03-23

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2018-12-31	$71,710 Δ	—	—	10-K, filed 2020-03-12
2017-12-31	$0 Δ	—	—	10-K, filed 2019-03-15
2016-12-31	$0 Δ	—	—	10-K, filed 2018-03-23